MODULATING TOLL-LIKE RECEPTOR 4 SIGNALING PATHWAY PROTECTS MICE FROM EXPERIMENTAL COLITIS
スポンサーリンク
概要
- 論文の詳細を見る
Background/Aim: Several reports have indicated that environmental factors and defects in innate immunity are central to the pathogenesis of inflammatory bowel disease (IBD). Although bacteria producing lipopolysaccharide (LPS), which is a Toll-like receptor (TLR) 4 agonist, play a crucial role in the development of experimental colitis, LPS tolerance following initial exposure to LPS can result in a state of hyporesponsiveness to subsequent LPS challenge. Therefore, we initiated this study to explore the role of LPS tolerance in the development of colitis. Methods: Dextran sulfate sodium (DSS) colitis was induced in Balb/c mice with or without daily intraperitoneal administration of LPS. Disease activity and cytokine mRNA expression in the colon were evaluated. To confirm LPS tolerance, mouse conventional bone marrow-derived dendritic cells (BMDC) were preincubated with or without LPS, and were restimulated with LPS 24 h after first exposure. Cytokine production was measured by ELISA, and mRNA expression was evaluated by RT-PCR. Furthermore, we investigated the expression of negative regulators of LPS tolerance in BMDC. Results: Administration of LPS significantly suppressed colonic inflammation of DSS-induced colitis. After subsequent stimulation with LPS, TNF-α production was reduced in BMDC. IRAK-M, a negative regulator of TLR4 signaling, mRNA expression was up-regulated in LPS-treated BMDC. Conclusion: LPS tolerance was able to protect mice from DSS-induced colitis, and IRAK-M participated in this tolerance. Taken together, these observations suggest that loss of exposure to LPS is involved in the pathogenesis of IBD.
- 福島医学会の論文
福島医学会 | 論文
- 福島県立女子医学専門学校元教授 故新井八郎先生の臨床および剖検記録--重症肺炎を合併した脳梗塞症
- 全人的医療への道 : 患者に寄り添う医療
- 難治性腹水を伴う肝硬変症例に対するTIPSの経験
- 福島県立医科大学の漢方医学教育と卒後研修 : 医学部3年生に対するアンケート調査結果
- 症例報告 妊娠中に発見された,左骨盤漏斗靱帯に発生した副卵巣成熟奇形腫の1症例